Course for Brain Fatigue After Graves' Disease Controlled Study

Recruiting N/A Interventional Study
Graves Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 72
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
96 (estimated)
Sponsor
Vastra Gotaland Region · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
BACKGROUND. Mental fatigue (MF) is common in the most common form of hyperthyroidism, Graves' disease (GD). Clinically, MF is the primary mental symptom in patients with GD and is characterized by difficulties maintaining attention, exhaustion during cognitively demanding tasks, memory difficulties, irritability, and emotional lability. It may be the main contributing factor to the continued low q…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18-72 years old * 15-72 months since first Graves' diagnosis * high free thyroxin and thyroid antibodies (TRAb) at diagnosis * euthyroid the last 6 months normal thyroid hormone levels at inclusion * symptoms on MF in connection to Graves diagnosis * MF-scale ≥10.5 points Exc…
Contacts

Agneta Lindo

+4676-6185481

agneta.lindo@vgregion.se

CONTACT